StockDuty ← Dashboard Aug 13, 2026 12:52 AM ET
SignalCorporate

MAXCYTE REITERATES $30M-$32M 2026 REVENUE OUTLOOK AS GENENTECH PARTNERSHIP EXPANDS ENTERPRISE MODEL - SEEKINGALPHA

MAXCYTE REITERATES $30M-$32M 2026 REVENUE OUTLOOK AS GENENTECH PARTNERSHIP EXPANDS ENTERPRISE MODEL - SEEKINGALPHA

What changed
MAXCYTE REITERATES $30M-$32M 2026 REVENUE OUTLOOK AS GENENTECH PARTNERSHIP EXPANDS ENTERPRISE MODEL - SEEKINGALPHA
Why it matters
MAXCYTE REITERATES $30M-$32M 2026 REVENUE OUTLOOK AS GENENTECH PARTNERSHIP EXPANDS ENTERPRISE MODEL - SEEKINGALPHA — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →